The coming Sunshine Act changes will be expensive for Ortho Companies

Proposed Changes to the Sunshine Act Will Be Expensive for Medtech Companies (OrthoSpineNews)

Proposed revisions to the Physician Payments Sunshine Act from the Centers for Medicare & Medicaid Services could prove expensive for some medical device companies.

By Brian Bohnenkamp In July 2014, the Centers for Medicare and Medicaid Services (“CMS”) issued proposed revisions to the rules governing the reporting requirements under the federal Physician Payments Sunshine Act (which CMS refers to as the Open Payments requirements).   Two of the proposed changes – if adopted – could have a s...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top